en
Scientific article
English

Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs

Published inJournal of virology, vol. 74, no. 10, p. 4868-4876
Publication date2000
Abstract

Aminooxypentane (AOP)-RANTES efficiently and specifically blocks entry of non-syncytium-inducing (NSI), CCR5-tropic (R5) human immunodeficiency virus type 1 (HIV-1) into host cells. Inhibition appears to be mediated by increased intracellular retention of the CCR5 coreceptor- AOP-RANTES complex and/or competitive binding of AOP-RANTES with NSI R5 HIV-1 isolates for CCR5. Although AOP-RANTES and other beta-chemokine analogs are potent inhibitors, the extreme heterogeneity of the HIV-1 envelope glycoproteins (gp120 and gp41) and variable coreceptor usage may affect the susceptibility of variant HIV-1 strains to these drugs. Using the same peripheral blood mononuclear cells (PBMC) with all isolates, we observed a significant variation in AOP-RANTES inhibition of 13 primary NSI R5 isolates; 50% inhibitory concentrations (IC(50)) ranged from 0.04 nM with HIV-1(A-92RW009) to 1.3 nM with HIV-1(B-BaL). Experiments performed on the same isolate (HIV-1(B-BaL)) with PBMC from different donors revealed no isolate-specific variation in AOP-RANTES IC(50) values but did show a considerable difference in virus replication efficiency. Exclusive entry via the CCR5 coreceptor by these NSI R5 isolates suggests that variable inhibition by AOP-RANTES is not due to alternative coreceptor usage but rather differential CCR5 binding. Analysis of the envelope V3 loop sequence linked a threonine or arginine at position 319 (numbering based on the HXB2 genome) with AOP-RANTES resistance. With the exception of one isolate, A319 was associated with increased sensitivity to AOP-RANTES inhibition. Distribution of AOP-RANTES IC(50) values with these isolates has promoted ongoing screens for new CCR5 agonists that show broad inhibition of HIV-1 variants.

Keywords
  • Amino Acid Sequence
  • Anti-HIV Agents/pharmacology
  • Cell Line
  • Chemokine CCL5/analogs & derivatives/pharmacology
  • Drug Resistance
  • Microbial
  • Giant Cells/physiology
  • HIV Envelope Protein gp120/genetics
  • HIV Envelope Protein gp160/genetics
  • HIV Infections/virology
  • HIV-1/drug effects/genetics/isolation & purification/physiology
  • Humans
  • Inhibitory Concentration 50
  • Leukocytes
  • Mononuclear/virology
  • Molecular Sequence Data
  • Peptide Fragments/genetics
  • Receptors
  • CCR5/metabolism
Research group
Citation (ISO format)
TORRE, V S et al. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs. In: Journal of virology, 2000, vol. 74, n° 10, p. 4868–4876. doi: 10.1128/JVI.74.10.4868-4876.2000
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0022-538X
460views
2downloads

Technical informations

Creation10/26/2012 9:13:00 AM
First validation10/26/2012 9:13:00 AM
Update time03/14/2023 8:00:59 PM
Status update03/14/2023 8:00:59 PM
Last indexation01/16/2024 1:07:00 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack